XASX
AHX
Market cap114mUSD
Feb 06, Last price
0.88AUD
Name
Apiam Animal Health Ltd
Chart & Performance
P/E
197.61
P/S
0.79
EPS
0.00
Div Yield, %
2.29%
Shrs. gr., 5y
9.97%
Rev. gr., 5y
11.83%
Revenues
207m
+1.11%
Net income
832k
-83.13%
CFO
18m
-6.56%
Dividend
Sep 02, 20250.01 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Apiam Animal Health Limited, an Australian-based, vertically integrated company, delivers a wide array of veterinary products and services for both production animals (livestock) and companion animals (pets). Its operations are segmented into specialized areas: Dairy and Mixed animal health, Feedlots, and Pigs. Beyond direct veterinary care, Apiam's comprehensive offerings encompass veterinary wholesale, diagnostic laboratory functions, custom vaccine creation, logistics, and additional ancillary services. The company provides specific expertise across various animal categories, including companion animals, dairy herds, swine, poultry, beef feedlots, equine, sheep, and genetic services. Leveraging technology, Apiam also offers telemedicine, remote video headgear, dedicated health management applications for livestock systems, benchmarking databases, and sophisticated herd management software. General animal health products are made accessible via its e-commerce platform. All services are primarily rendered through its network of animal veterinary clinics. Apiam Animal Health was established in 1998 and is headquartered in Bendigo, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||